Emergence of carbapenem-resistant ST131 escherichia coli carrying blaOXA-244 in germany, 2019 to 2020

Sybille Welker; Sébastien Boutin; Thomas Miethke; Klaus Heeg; Dennis Nurjadi

doi:10.2807/1560-7917.ES.2020.25.46.2001815

Emergence of carbapenem-resistant ST131 escherichia coli carrying bla_OXA-244 in germany, 2019 to 2020

Sybille Welker, Sébastien Boutin, Thomas Miethke, Klaus Heeg, Dennis Nurjadi^*

^*Korrespondierende/r Autor/-in für diese Arbeit

20 Zitate (Scopus)

Abstract

The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 Escherichia coli in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing E. coli may be underreported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 E. coli is of clinical relevance and should be monitored closely.

Originalsprache	Englisch
Zeitschrift	Eurosurveillance
Jahrgang	25
Ausgabenummer	46
ISSN	1025-496X
DOIs	https://doi.org/10.2807/1560-7917.ES.2020.25.46.2001815
Publikationsstatus	Veröffentlicht - 11.2020

Fördermittel

Träger	Trägernummer
UK Research and Innovation	106157

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

DFG-Fachsystematik

2.21-03 Medizinische Mikrobiologie und Mykologie, Hygiene, Molekulare Infektionsbiologie
2.21-05 Immunologie

Dokumente

10.2807/1560-7917.ES.2020.25.46.2001815

Weitere Links

Link to publication in Scopus

Zitieren

@article{8f53b48a33964d21a8ac5df985ec617a,

title = "Emergence of carbapenem-resistant ST131 escherichia coli carrying blaOXA-244 in germany, 2019 to 2020",

abstract = "The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 Escherichia coli in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing E. coli may be underreported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 E. coli is of clinical relevance and should be monitored closely.",

author = "Sybille Welker and S{\'e}bastien Boutin and Thomas Miethke and Klaus Heeg and Dennis Nurjadi",

year = "2020",

month = nov,

doi = "10.2807/1560-7917.ES.2020.25.46.2001815",

language = "English",

volume = "25",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "46",

}

TY - JOUR

T1 - Emergence of carbapenem-resistant ST131 escherichia coli carrying blaOXA-244 in germany, 2019 to 2020

AU - Welker, Sybille

AU - Boutin, Sébastien

AU - Miethke, Thomas

AU - Heeg, Klaus

AU - Nurjadi, Dennis

PY - 2020/11

Y1 - 2020/11

N2 - The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 Escherichia coli in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing E. coli may be underreported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 E. coli is of clinical relevance and should be monitored closely.

AB - The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 Escherichia coli in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing E. coli may be underreported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 E. coli is of clinical relevance and should be monitored closely.

UR - https://www.scopus.com/pages/publications/85096459516

U2 - 10.2807/1560-7917.ES.2020.25.46.2001815

DO - 10.2807/1560-7917.ES.2020.25.46.2001815

M3 - Journal articles

C2 - 33213685

AN - SCOPUS:85096459516

SN - 1025-496X

VL - 25

JO - Eurosurveillance

JF - Eurosurveillance

IS - 46

ER -